GFR Decline as an Alternative End Point in Clinical Trials to Prevent ESRD: Are We Increasing Treatment Uncertainty for the Sake of Feasibility?
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- December 2014
has subject area
- 1103 Clinical Sciences (FoR)
- 1117 Public Health and Health Services (FoR)
- Endpoint Determination (MeSH)
- Glomerular Filtration Rate (MeSH)
- Humans (MeSH)
- Kidney Failure, Chronic (MeSH)
- Randomized Controlled Trials as Topic (MeSH)
- Urology & Nephrology (Science Metrix)